Notice of Interim Results, Investor Presentation

By

Regulatory News | 02 Sep, 2024

Updated : 07:01

RNS Number : 4079C
Itaconix PLC
02 September 2024
 

For release: 2 September 2024                                                                                                                                         

 

Itaconix plc


("Itaconix" or "the Company")


Notice of Interim Results, Analyst and Investor Presentation

 

Itaconix plc (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used to decarbonise everyday consumer products, announces that its Interim Results for the period ended 30 June 2024 will be released on 10 September 2024.

Investor Presentation

The Company will also hold a live online presentation for investors and analysts at 14:00 BST on 10 September 2024, on the Investor Meet Company platform. The online presentation is open to all shareholders and any interested parties.

Participants can sign up to the Investor Meet Company platform and add to join the live presentation via: https://www.investormeetcompany.com/itaconix-plc/register-investor

Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00 BST the day before the meeting or at any time during the live presentation.

- Ends -

 

Enquiries:

 

Itaconix plc

+1 603 775 4400

John R. Shaw / Laura Denner


Rosewood

+44 (0) 207 653 8704

Financial PR

John West / Llew Angus


Canaccord Genuity

+44 (0) 7523 8000

Nominated Adviser and Sole Broker

 

Adam James / Harry Pardoe


 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's products contribute to the global low carbon economy.

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORPMMRTMTAJBBI

Last news